Literature DB >> 16416355

Mortality and morbidity in extremely preterm infants (22 to 26 weeks of gestation): Austria 1999-2001.

Christina Weber1, Manfred Weninger, Katrin Klebermass, Gernot Reiter, Gabriele Wiesinger-Eidenberger, Mathias Brandauer, Raimund Kraschl, Karl Lingitz, Renate Grassl-Jurek, Walter Sterniste, Bernd Balluch, Micha Kolmer, Robert Bruckner, Gerolf Schweintzger, Hans Salzer, Irene Rath, Peter Kubitsch, Werner Zissler, Wilhelm Müller, Berndt Urlesberger.   

Abstract

OBJECTIVE: The aim of this retrospective study was to analyze the mortality and morbidity for extremely preterm infants with a gestational age from 22 to 26 weeks. All infants were born in Austria during the years 1999-2001.
METHODS: Data were collected from 16 neonatal intensive care units in Austria. Main outcome criteria were mortality, the rates of chronic lung disease (CLD) and severe retinopathy of prematurity (ROP, stage > or =3) to determine the short-term outcome; the rate of cerebral palsy (CP) at the corrected age of twelve months to assess the long-term outcome.
RESULTS: Overall, 796 preterm infants with a gestational age less than 27 weeks were born in Austria and 581 (73%) were registered as live-born infants. Of those live born, 508 (87%) were analyzed. The mortality rates were 83%, 76%, 43%, 26% and 13% for 22, 23, 24, 25 and 26 weeks' gestation, respectively. The rates of CLD were 33% (22 weeks), 36% (23 weeks), 42% (24 weeks), 31% (25 weeks) and 22% (26 weeks). The rates of ROP of stage > or =3 were 0% (22 weeks), 29% (23 weeks), 23% (24 weeks), 18% (25 weeks) and 10% (26 weeks). The rates of CP at the corrected age of 12 months were 33%, 50%, 33%, 26% and 25% for 22, 23, 24, 25 and 26 weeks' gestation, respectively.
CONCLUSIONS: The results of this national study are in accordance with the international literature: mortality and morbidity increased with decreasing gestational age.

Entities:  

Mesh:

Year:  2005        PMID: 16416355     DOI: 10.1007/s00508-005-0468-y

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  8 in total

Review 1.  Retinopathy of prematurity.

Authors:  Ann Hellström; Lois E H Smith; Olaf Dammann
Journal:  Lancet       Date:  2013-06-17       Impact factor: 79.321

2.  Identification of Gene Mutations in Atypical Retinopathy of Prematurity Cases.

Authors:  Yian Li; Jiakai Li; Xiang Zhang; Jie Peng; Jing Li; Peiquan Zhao
Journal:  J Ophthalmol       Date:  2020-08-20       Impact factor: 1.909

3.  Renal failure, comorbidity and mortality in preterm infants.

Authors:  Dagmar Csaicsich; Nina Russo-Schlaff; Agnes Messerschmidt; Manfred Weninger; Arnold Pollak; Christoph Aufricht
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

4.  Response to neonatal anesthesia: effect of sex on anatomical and behavioral outcome.

Authors:  S Rothstein; T Simkins; J L Nuñez
Journal:  Neuroscience       Date:  2008-02-05       Impact factor: 3.590

5.  Incidence and risk factors of retinopathy of prematurity in two neonatal intensive care units in North and South China.

Authors:  Yi Chen; Deng Xun; Ya-Cong Wang; Bin Wang; Shao-Hui Geng; Hui Chen; Yan-Tao Li; Xiao-Xin Li
Journal:  Chin Med J (Engl)       Date:  2015-04-05       Impact factor: 2.628

6.  Low mortality and short-term morbidity in very preterm infants in Austria 2011-2016.

Authors:  U Kiechl-Kohlendorfer; B Simma; B Urlesberger; U Maurer-Fellbaum; M Wald; M Wald; M Weissensteiner; D Ehringer-Schetitska; A Berger
Journal:  Acta Paediatr       Date:  2019-03-25       Impact factor: 2.299

7.  Blood protein profiles related to preterm birth and retinopathy of prematurity.

Authors:  Hanna Danielsson; Abdellah Tebani; Wen Zhong; Linn Fagerberg; Nele Brusselaers; Anna-Lena Hård; Mathias Uhlén; Ann Hellström
Journal:  Pediatr Res       Date:  2021-04-24       Impact factor: 3.953

8.  Long-term effects of neonatal single or multiple isoflurane exposures on spatial memory in rats.

Authors:  Kathy L Murphy; Mark G Baxter
Journal:  Front Neurol       Date:  2013-07-08       Impact factor: 4.003

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.